45 Results

People

  1. Amar
    Amar
  2. Keefe
    Keefe
  3. Roistacher
    Roistacher
  4. Thaler
    Thaler
  5. Zhang
    Zhang
  6. Coyle
    Coyle
  7. Foley
    Foley
  8. Korenstein
    Korenstein
  9. Kris
    Kris
  10. Mcaleer
    Mcaleer

Groups

  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (10)
  3. Survivorship Research (10)
  4. Division of Subspecialty Medicine (8)
  5. Hematologic Malignancies, Division of (8)
  6. Center for Hematologic Malignancies (7)
  7. Anesthesiology and Critical Care Medicine (6)
  8. Cardiology (5)
  9. Radiology, Department of (5)
  10. Anesthesiology Service (4)
  1. "electrocardiogram"
Formats
  1. Journal Article (42)
  2. Editorial (1)
  3. Miscellaneous (1)
  4. Review (1)
Groups
  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (10)
  3. Survivorship Research (10)
  4. Division of Subspecialty Medicine (8)
  5. Hematologic Malignancies, Division of (8)
  6. Center for Hematologic Malignancies (7)

More Groups

People
  1. Howard Thaler (5)
  2. David Amar (3)
  3. Deborah Keefe (3)
  4. Hao Zhang (3)
  5. Nancy Roistacher (3)
  6. Deborah Korenstein (2)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer (3)
  3. Future Oncology (2)
  4. JAMA Internal Medicine (2)
  5. Journal of Clinical Pharmacology (2)
  6. American Journal of Health-System Pharmacy (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Medical Association (3)
  3. Elsevier Science, Inc. (3)
  4. Lippincott Williams & Wilkins (3)
  5. Springer (3)
  6. Wiley Blackwell (3)

More Publishers

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer
    Journal Article

    Dorff, T.; Horvath, L. G.; Autio, K.; Bernard-Tessier, A.; Rettig, M. B.; Machiels, J. P.; Bilen, M. A.; Lolkema, M. P.; Adra, N.; Rottey, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: A phase 1, dose-finding and expansion study
    Journal Article

    Garcia-Manero, G.; Goldberg, A. D.; Winer, E. S.; Altman, J. K.; Fathi, A. T.; Odenike, O.; Roboz, G. J.; Sweet, K.; Miller, C.; Wennborg, A.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors
    Journal Article

    Park, H.; Shapiro, G. I.; Gao, X.; Mahipal, A.; Starr, J.; Furqan, M.; Singh, P.; Ahrorov, A.; Gandhi, L.; Ghosh, A.; more...
    ESMO Open (2022)

    Fulltext@MSK | Save
  • Longitudinal content analysis of the characteristics and expected impact of low-value services identified in US Choosing Wisely recommendations
    Journal Article

    Ganguli, I.; Thakore, N.; Rosenthal, M. B.; Korenstein, D.
    JAMA Internal Medicine (2022)

    Fulltext@MSK | Save
  • Preliminary study: Myocardial T1 relaxation time in patients with ischemic findings and normal findings on coronary angiography
    Journal Article

    Bulut, S. S. D.; Nurili, F.; Öztürkeri, B.; Sakci, Z.; Bukte, Y.; Aras, Ö
    Revista Da Associacao Medica Brasileira (2021)

    Fulltext@MSK | Save
  • Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
    Journal Article

    Laurence, J.; Mulvey, J. J.; Seshadri, M.; Racanelli, A.; Harp, J.; Schenck, E. J.; Zappetti, D.; Horn, E. M.; Magro, C. M.
    Clinical Immunology (2020)

    Fulltext@MSK | Save
  • Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma
    Journal Article

    Whitman, J.; Kardosh, A.; Diaz, L. Jr; Fong, L.; Hope, T.; Onodera, C.; Joseph, N.; Le, D.; Fisher, G.; Bergsland, E.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma
    Journal Article

    Stone, A.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Wu, X.; Cheung, N. K.; Sklar, C. A.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • 2018 update on medical overuse
    Review

    Morgan, D. J.; Dhruva, S. S.; Coon, E. R.; Wright, S. M.; Korenstein, D.
    JAMA Internal Medicine (2019)

    Fulltext@MSK | Save
  • Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
    Journal Article

    Puzanov, I.; Diab, A.; Abdallah, K.; Bingham, C. O. 3rd; Brogdon, C.; Dadu, R.; Hamad, L.; Kim, S.; Lacouture, M. E.; LeBoeuf, N. R.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save